Prognostic significance of major histocompatibility complex class II antigens (HLA-DR) in normal colonic mucosa, tubulovillous adenoma, and invasive colonic carcinoma.
Tamiolakis
Demetrio
D
Department of Cytology, General Hospital of Chania, Crete, Greece. cyto@chaniahospital.gr
Nicolaidou
Sylvia
S
Bolioti
Sophia
S
Tzilivaki
Anna
A
D018253:Adenoma, Villous / Q000276:immunology* / Q000473:pathology; D000368:Aged; D015704:CD4 Antigens / Q000032:analysis; D002277:Carcinoma / Q000276:immunology* / Q000473:pathology; D003110:Colonic Neoplasms / Q000276:immunology* / Q000473:pathology; D005260:Female; D006683:HLA-DQ Antigens / Q000032:analysis; D006684:HLA-DR Antigens / Q000032:analysis; D006801:Humans; D007150:Immunohistochemistry; D007413:Intestinal Mucosa / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D011379:Prognosis
D015704:CD4 Antigens; D006683:HLA-DQ Antigens; D006684:HLA-DR Antigens